These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 7579063)

  • 1. Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.
    Kronenberg F; König P; Neyer U; Auinger M; Pribasnig A; Lang U; Reitinger J; Pinter G; Utermann G; Dieplinger H
    J Am Soc Nephrol; 1995 Jul; 6(1):110-20. PubMed ID: 7579063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
    Kimak E; Solski J
    Ren Fail; 2002 Mar; 24(2):187-95. PubMed ID: 12071592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.
    Milionis HJ; Elisaf MS; Tselepis A; Bairaktari E; Karabina SA; Siamopoulos KC
    Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease.
    Kim SB; Yang WS; Kang ES; Min WK; Park JS
    Perit Dial Int; 1997; 17(3):236-42. PubMed ID: 9237283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients.
    Wanner C; Bartens W; Walz G; Nauck M; Schollmeyer P
    Nephrol Dial Transplant; 1995; 10(1):75-81. PubMed ID: 7724034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated lipoprotein(a) and fibrinogen levels [corrected] increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patients.
    Bartens W; Nauck M; Schollmeyer P; Wanner C
    Perit Dial Int; 1996; 16(1):27-33. PubMed ID: 8616169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein (a) levels in end-stage renal failure and renal transplantation.
    Barbagallo CM; Averna MR; Sparacino V; Galione A; Caputo F; Scafidi V; Amato S; Mancino C; Cefalù AB; Notarbartolo A
    Nephron; 1993; 64(4):560-4. PubMed ID: 8366981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
    Milionis HJ; Elisaf MS; Karabina SA; Bairaktari E; Tselepis AD; Siamopoulos KC
    Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alterations of serum lipoprotein (a) levels in continuous ambulatory peritoneal dialysis (CAPD) patients].
    Tanaka S
    Nihon Jinzo Gakkai Shi; 1994 Jun; 36(6):746-51. PubMed ID: 8084076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma level of lipoprotein Lp(a) is high in predialysis or hemodialysis, but not in CAPD.
    Kandoussi A; Cachera C; Pagniez D; Dracon M; Fruchart JC; Tacquet A
    Kidney Int; 1992 Aug; 42(2):424-5. PubMed ID: 1405325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of increasing serum albumin on serum lipoprotein(a) concentration in patients receiving CAPD.
    Yang WS; Min WK; Park JS; Kim SB
    Am J Kidney Dis; 1997 Oct; 30(4):507-13. PubMed ID: 9328365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is atherosclerosis accelerated by CAPD?
    Kawaguchi Y; Kubo H; Yamamoto H; Nakayama M; Yokoyama K; Shigematsu T; Sakai O
    Perit Dial Int; 1996; 16 Suppl 1():S223-30. PubMed ID: 8728197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alterations of Lp (a) lipoprotein in patients with chronic renal failure treated by continuous ambulatory peritoneal dialysis].
    Takegoshi T; Kitoh C; Shimada T; Kawai K; Yamazaki Y; Mabuchi H
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):757-63. PubMed ID: 8377289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
    Dieplinger H; Lackner C; Kronenberg F; Sandholzer C; Lhotta K; Hoppichler F; Graf H; König P
    J Clin Invest; 1993 Feb; 91(2):397-401. PubMed ID: 8432847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease.
    Querfeld U; Lang M; Friedrich JB; Kohl B; Fiehn W; Schärer K
    Pediatr Res; 1993 Dec; 34(6):772-6. PubMed ID: 8108191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration of Lp(a) and other apolipoproteins in predialysis, hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
    Kimak E; Solski J; Janicka L; Ksaziek A; Janicki K
    Clin Chem Lab Med; 2000 May; 38(5):421-5. PubMed ID: 10952225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis.
    Siamopoulos KC; Elisaf MS; Bairaktari HT; Pappas MB; Sferopoulos GD; Nikolakakis NG
    Perit Dial Int; 1995; 15(8):342-7. PubMed ID: 8785232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.
    Sechi LA; Zingaro L; Catena C; Perin A; De Marchi S; Bartoli E
    Kidney Int; 1999 Sep; 56(3):1049-57. PubMed ID: 10469373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.